The latest cancer drugs news
Browsing: Cancer Drug News
Advanced breast cancer: now considerable added benefit of trastuzumab deruxtecan
The antibody-drug conjugate trastuzumab deruxtecan has been approved since January 2021 for pretreated adults with…
FDA approves sacituzumab govitecan-hziy for HR-positive breast cancer
On February 3, 2023, the Food and Drug Administration (FDA) approved sacituzumab govitecan-hziy for patients with…
Drug combination shows potential in aggressive leukaemia
Despite recent therapeutic advances, acute myeloid leukaemia (AML) continues to be associated with poor outcomes…
FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer
On January 26, 2023, the Food and Drug Administration (FDA) approved pembrolizumab for adjuvant treatment following…
FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
On January 27, 2023, the Food and Drug Administration (FDA) approved elacestrant for postmenopausal women…
ADAURA shows significant disease-free survival for NSCLC patients
New data from a Yale Cancer Center-led clinical trial shows improved rates of survival and…
FDA approves zanubrutinib for chronic lymphocytic leukaemia or small lymphocytic lymphoma
On January 19, 2023, the Food and Drug Administration (FDA) approved zanubrutinib for chronic lymphocytic leukaemia…
Advanced cervical cancer: pembrolizumab prolongs life
Pembrolizumab has recently been approved in combination with chemotherapy for the treatment of women with…
FDA grants accelerated approval to mosunetuzumab-axgb for relapsed or refractory follicular lymphoma
On December 22, 2022, the Food and Drug Administration (FDA) granted accelerated approval to mosunetuzumab-axgb…
FDA approves “glowing tumour” imaging drug to aid lung cancer surgery
The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent pafolacianine for use in…